MediGene AG | |
Stock Exchange | Other OTC |
EPS |
$0.91 |
Market Cap |
$204.19 M |
Shares Outstanding |
24.55 M |
Public Float |
- |
Address |
Lochhamer Straße 11 Martinsried Bayern (Bavaria) 82152 Germany |
Employees | - |
Website | http://www.medigene.de |
Updated | 07/08/2019 |
MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. It focuses on the development of personalized T-cell based immunotherapies. It operates through the Immunotherapies and Other products segments. |